Breast Cancer
Miami Breast Cancer Conference Coverage
From the Journals
Oral contraceptive use confers long-term cancer protection
A new analysis of the General Practitioners’ Oral Contraception Study offers reassurance about the use of combined oral contraceptives and cancer...
From the Journals
Scalp cooling reduces hair loss in 50% or more of women in separate studies
Scalp cooling resulted in significant reductions in hair loss in about half of all women who were treated before, during, and after chemotherapy...
From the Journals
Lipid-lowering meds benefit some breast cancer patients
Patients with early-stage, hormone-receptor positive breast cancer who used cholesterol-lowering medication at baseline of a long-term randomized...
From the Journals
Optimal adjuvant endocrine therapy use in breast cancer remains elusive
Appropriate use of adjuvant endocrine therapy for breast cancer has increased over the last decade, but optimal use has not been achieved.
Conference Coverage
START again shows safety of hypofractionated doses in early breast cancer
AMSTERDAM – Analyses of patient-reported outcomes in the UK START A and B trials show that radiation doses greater than 2 Gy to the...
Conference Coverage
Survival better with breast-conserving therapy for early cancers
AMSTERDAM – Breast cancer–specific survival and overall survival were better among women who had breast-conserving therapy (BCT) compared with...
Conference Coverage
Axial radiotherapy noninferior to cALND in early invasive breast cancer
Women with early breast cancer with only sentinel lymph node involvement may be able to be spared morbidity from axillary dissection.
From the Journals
Residual disease burden is prognostic across breast cancer phenotypes
The Residual Cancer Burden measure is prognostic of long-term survival across all three phenotypic subtypes of breast cancer.
From the Journals
Left ventricle dose predicts heart events after BC radiation
The risk of acute coronary events following radiotherapy for breast cancer is better predicted by the volume of the left ventricle that received 5...
Conference Coverage
Circulating microRNAs may predict breast cancer treatment response
SAN ANTONIO – Circulating microRNAs may predict treatment response in HER2-positive breast cancer patients treated with neoadjuvant therapy,...